platinum has been researched along with Melanoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 8 (38.10) | 2.80 |
| Authors | Studies |
|---|---|
| Jalili, A; Kinaciyan, T; Marquart, E; Mothes-Luksch, N; Wagner, SN | 1 |
| Abogosh, A; Ahmad, S; Aldawood, E; Alhazzani, K; Alhoshani, A; Alotaibi, MR; Isab, AA; Sobeai, HMA; Sulaiman, AAA | 1 |
| Daneshvar, F; Haghighi, H; Salehi, F; Sattarahmady, N; Tamaddon, P; Zahraie, N | 1 |
| Daneshvar, F; Dehdari Vais, R; Karimi, M; Mosleh-Shirazi, MA; Salehi, F; Sattarahmady, N | 1 |
| Acunha, TV; Borba, VM; Collares, T; Couto, GK; Iglesias, BA; Junior, JCR; Oliveira, TL; Pacheco, BS; Segatto, NV; Seixas, FK | 1 |
| Bartomeu Garcia, C; López Ruiz, A; Navarro Gallón, S; Webster, TJ | 1 |
| Aguiar, MC; Botelho, MF; Brites, G; Brito, AF; Casalta-Lopes, J; Gonçalves, AC; Laranjo, M; Nascimento, BFO; Pereira, NAM; Pineiro, M; Pinho E Melo, TMVD; Sarmento-Ribeiro, AB | 1 |
| Acunha, TV; Collares, T; Damé Simões, L; Iglesias, BA; Klein Couto, G; Pacheco, BS; Paschoal, JD; Rodrigues, JC; Seixas, FK | 1 |
| Luo, Y; Pei, S; Xiao, Y; Xu, J; Zhu, X | 1 |
| Baggaley, E; Botchway, SW; Colley, HE; Green, NH; Haycock, JW; MacNeil, S; Raza, A; Sazanovich, IV; Weinstein, JA | 1 |
| Chen, T; Fan, C; Fu, X; Huang, J; Lan, G; Liang, Y; Xie, Q; Zheng, W; Zhou, Y | 1 |
| Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R | 1 |
| Lage, H; Liedert, B; Materna, V; Schadendorf, D; Thomale, J | 1 |
| Lage, H; Liedert, B; Materna, V; Thomale, J | 1 |
| Björn, E; Ericson, C; Naredi, P; Nguyen, TT; Nöjd, M; Nygren, Y | 1 |
| Duncan, R; Evagorou, EG; Gianasi, E; Keddle, A; Wasil, M; Wilson, G | 1 |
| Benjamin, RS; Mavligit, GM; McBride, CM; Pritchard, JD; Wallace, S | 1 |
| de Vries, EG; Guchelaar, HJ; Hoekstra, HJ; Oosterhuis, JW; Schraffordt Koops, H; Uges, DR | 1 |
| Edgren, M; Fichtinger-Schepman, AM; Hansson, J; Ringborg, U | 1 |
| Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA | 1 |
| Hansson, J; Lewensohn, R; Ringborg, U | 1 |
21 other study(ies) available for platinum and Melanoma
| Article | Year |
|---|---|
Anaphylactic reaction to carboplatin diagnosed by skin testing-a reliable tool in platinum-based immediate-type hypersensitivity reactions.
Topics: Anaphylaxis; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Hypersensitivity; Erythema; Female; Humans; Melanoma; Middle Aged; Ovarian Neoplasms; Platinum | 2023 |
In vitro and in vivo antitumor studies of potential anticancer agents of platinum(II) complexes of dicyclopentadiene and dithiocarbamates§.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Coordination Complexes; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Humans; Indenes; Melanoma; Mice; Platinum | 2022 |
Pulsed sonodynamic therapy of melanoma cancer cells using nanoparticles of and mesoporous platinum.
Topics: Cell Line, Tumor; Humans; Melanoma; Metal Nanoparticles; Nanoparticles; Nanostructures; Neoplasms; Platinum; Reactive Oxygen Species; Ultrasonic Therapy | 2023 |
Enhanced melanoma cell-killing by combined phototherapy/radiotherapy using a mesoporous platinum nanostructure.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Laser Therapy; Melanoma; Mice; Nanostructures; Platinum; Radiation-Sensitizing Agents; Radiotherapy; Reactive Oxygen Species; Surface Properties; Tumor Cells, Cultured | 2019 |
Tetra-cationic platinum(II) porphyrins like a candidate photosensitizers to bind, selective and drug delivery for metastatic melanoma.
Topics: Animals; Apoptosis; Binding Sites; Caspase 3; Cations; Cell Cycle Checkpoints; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Drug Carriers; Gene Expression Regulation; Humans; Light; Melanoma; Molecular Docking Simulation; Photosensitizing Agents; Platinum; Porphyrins; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Novel Silver-Platinum Nanoparticles for Anticancer and Antimicrobial Applications.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glioblastoma; Humans; Melanoma; Metal Nanoparticles; Microbial Sensitivity Tests; Platinum; Pseudomonas aeruginosa; Silver; Staphylococcus aureus | 2020 |
Platinum(II) ring-fused chlorins as efficient theranostic agents: Dyes for tumor-imaging and photodynamic therapy of cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Fluorescent Dyes; Humans; Melanoma; Molecular Structure; Optical Imaging; Photochemotherapy; Platinum; Porphyrins; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2020 |
Zinc(II), copper(II) and nickel(II) ions improve the selectivity of tetra-cationic platinum(II) porphyrins in photodynamic therapy and stimulate antioxidant defenses in the metastatic melanoma lineage (A375).
Topics: Antioxidants; Copper; Humans; Melanoma; Nickel; Photochemotherapy; Photosensitizing Agents; Platinum; Porphyrins; Zinc | 2020 |
Combined chemotherapy of platinum and fluorouracil promotes T cell-mediated antitumor immunity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Therapy, Combination; Fluorouracil; Humans; Melanoma; Mice, Inbred C57BL; Neoplasms; NF-kappa B p50 Subunit; Oxaliplatin; Platinum; Stomach Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer | 2021 |
Oxygen Mapping of Melanoma Spheroids using Small Molecule Platinum Probe and Phosphorescence Lifetime Imaging Microscopy.
Topics: Cell Line, Tumor; Cell Proliferation; Humans; Immunohistochemistry; Luminescent Measurements; Melanoma; Microscopy, Fluorescence; Molecular Imaging; Molecular Probes; Oxygen; Platinum; Spheroids, Cellular; Tumor Burden; Tumor Cells, Cultured | 2017 |
Strategy to enhance the anticancer efficacy of X-ray radiotherapy in melanoma cells by platinum complexes, the role of ROS-mediated signaling pathways.
Topics: Cell Cycle; Cell Line, Tumor; DNA Damage; Humans; Ligands; Melanoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platinum; Radiation Tolerance; Radiotherapy; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2014 |
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays | 2016 |
Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin.
Topics: Antineoplastic Agents; Cisplatin; DNA Adducts; Drug Resistance, Neoplasm; G2 Phase; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Phenotype; Platinum; Skin Neoplasms; Transfection; Tumor Cells, Cultured | 2003 |
Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.
Topics: Adrenocortical Carcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Base Sequence; Caspase 3; Caspases; Cisplatin; Cross-Linking Reagents; DNA Adducts; DNA Repair; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Kinetics; Melanoma; Molecular Sequence Data; Ovarian Neoplasms; Platinum; RNA, Catalytic; Skin Neoplasms; Tumor Cells, Cultured | 2005 |
Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; DNA Adducts; DNA, Neoplasm; Female; Humans; Mass Spectrometry; Melanoma; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Sensitivity and Specificity; Subcellular Fractions | 2007 |
HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.
Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Screening Assays, Antitumor; Male; Melanoma; Methacrylates; Mice; Platinum; Tumor Cells, Cultured | 1999 |
Regression of regionally advanced melanoma after arterial infusion with cis-platinum and actinomycin-D.
Topics: Adult; Antineoplastic Agents; Dactinomycin; Female; Humans; Melanoma; Platinum; Propionibacterium acnes; Skin Neoplasms | 1979 |
Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
Topics: Adult; Aged; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Extremities; Fever; Histiocytoma, Benign Fibrous; Humans; Melanoma; Middle Aged; Osteosarcoma; Platinum; Tissue Distribution | 1992 |
Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin.
Topics: Cell Line; Cell Survival; Cisplatin; DNA, Neoplasm; Glutathione; Humans; Mechlorethamine; Melanoma; Melphalan; Platinum; Tumor Cells, Cultured | 1991 |
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured | 1991 |
Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis.
Topics: Cell Line; Cell Survival; Cisplatin; DNA Replication; Humans; Hydrogen-Ion Concentration; Lymphocytes; Melanoma; Platinum; Thymidine | 1988 |